Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

Bionomics On Threshold Of Discovery

Jan 30 2013 - Small Caps

Biotech stock Bionomics is undervalued as its therapeutics program has been enhanced with the acquisition of Eclipse, according to Bell Potter.


Treasure Chest: Buy The Aussie Against The Euro

Jan 30 2013 - Treasure Chest

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today sees a suggestion to play the AUD and NZD long against the EUR.


Have The Markets Gotten Ahead Of Themselves?

Jan 30 2013 - FYI

Forex.com’s Kathleen Brookes investigates the question on everyone’s lips: is it all getting a bit too much, too soon?


SMSFundamentals: Nobody Knows

Jan 30 2013 - SMSFundamentals

A multi-asset approach to reduce risks and volatility through cycles? PFP’s Tim Price discusses two unusual alternatives.


The Short Report

Jan 30 2013 - FYI

FNArena’s weekly update on short positions in the Australian share market.


Australian Stocks: What Happened Today?

Jan 29 2013 - Australia

A wrap of the day’s activity on the Australian stock market.


Can ResMed Continue To Deliver?

Jan 29 2013 - Australia

ResMed’s result was well received by brokers as it beat forecasts, but just how much more upside can be expected?


Papillon Reveals Potential At Fekola

Jan 29 2013 - Australia

The Fekola resource upgrade has inspired two brokers recommending the West African gold play as a potential high-return stock.


Oz Equities: Don’t Miss the Pullback

Jan 29 2013 - Technicals

Michael Gable of Novus Capital suggests a pullback in the ASX 200 is likely in the shorter term but is unlikely to be significant.


Uranium Up A Little More

Jan 29 2013 - Commodities

Market activity and the uranium spot price both heated up a little last week.


Analyse The Market From A Different Angle